A Phase III, double-blinded, multicenter, randomized study evaluating the efficacy and safety of neoadjuvant treatment with Atezolizumab or placebo in combination with Platinum-based chemotherapy in patients with resectable stage II, IIIa, or select IIIb Non−Small Cell Lung Cancer.
aktiv
3
Georgstraße 12
26121 Oldenburg
Tel: 0441 / 229 0
Fax: 0441 / 229 1607
Frank.Griesinger@Pius-Hospital.de
www.pius-hospital.de/kontakt
Professor Dr. med. Frank Griesinger
Pius-Hospital Oldenburg
Klinik für Hämatologie und Onkologie
Universitätsklinik Innere Medizin-Onkologie
Medizinischer Campus Universität Oldenburg